Table 2 DDKT opportunity according to PRA.

From: Impact of sensitization and ABO blood types on the opportunity of deceased-donor kidney transplantation with prolonged waiting time

Hospital cohort max PRA%

DDKT (N = 819)

Univariate model

Multivariate model

Yes, N (%)

sHR

95% CI

P-value

sHR

95% CI

P-value

 < 80%

744 (90.8)

Reference

  

Reference

  

80 ≪ 99%

59 (7.2)

0.66

0.51–0.86

0.002

0.64

0.49–0.83

 < 0.001

 ≥ 99%-

16 (2.0)

0.46

0.28–0.73

0.001

0.42

0.26–0.68

 < 0.001

Negative

525 (64.1)

Reference

  

Reference

  

Positive

294 (39.5)

0.88

0.76–1.01

0.065

0.85

0.74–0.99

0.032

Max PRA% (continuous value)

819 (100.0)

0.99

0.99–1.00

 < 0.001

0.99

0.99–1.00

 < 0.001

National cohort PRA

DDKT (N = 3311)

Univariate model

Multivariate model

Yes, N (%)

sHR

95% CI

P-value

sHR

95% CI

P-value

Negative

2072 (62.6)

Reference

  

Reference

  

Positive

1239 (37.4)

0.71

0.66–0.76

 < 0.001

0.72

0.67–0.77

 < 0.001

  1. Multivariate model adjusted for age, sex, ABO blood type and DM.
  2. Max PRA% defined as patients’ highest PRA% record.
  3. Negative PRA indicates max PRA% was 0%
  4. Max PRA% (cont) was treated as a continuous variable.
  5. CI confidence interval, DDKT deceased donor kidney transplantation, DM diabetes mellitus, max maximum, PRA panel reactive antibody, sHR subdistribution hazard ratio.
Back to article page